The role of hydroxychloroquine in pediatric rheumatology presents unique challenges and opportunities. In children with juvenile idiopathic arthritis and other autoimmune conditions,
hydroxychloroquine cost can offer significant benefits, but its use must be carefully balanced with considerations for growth, development, and long-term health, emphasizing the importance of specialized care and monitoring in pediatric populations.